Sidra Capital

Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division’s digital transformation goals and accelerate its precision medicine and genomics research programs. The MoU was signed at Microsoft Qatar’s Lusail office, by Dr. Khalid Fakhro, the Chief Research Officer from Sidra Medicine and Lana Khalaf, General Manager of Microsoft Qatar in the presence of representatives from both entities. The MoU signals a series of strategic collaborations and implementations that will enable Sidra Medicine’s research division to expedite its technology and cloud adoption on Microsoft’s ...